Common Inflammatory Pathways and Treatment Challenges in Psoriasis and Crohn’s Disease
Overview
This review highlights the partial immune convergence between psoriasis and Crohn’s disease, emphasizing shared inflammatory pathways such as TNF-α and IL-23.
Background
Psoriasis and Crohn’s disease are chronic immune-mediated inflammatory diseases that affect different barrier organs but share overlapping immune mechanisms.
Data Highlights
No numerical data or trial data provided in the source material.
Key Findings
Psoriasis and Crohn’s disease exhibit partial immune convergence shaped by tissue context.
Shared upstream pathways include TNF-α and IL-23-centered type 17 immunity.
Downstream effector pathways, particularly IL-17 responses, differ based on organ-specific factors.
Patients with psoriasis may have an increased prevalence of inflammatory bowel disease, particularly in severe cases.
Therapeutic options include TNF inhibitors and IL-23 inhibitors.
Clinical Implications
Consideration of shared immune pathways is important when treating patients with psoriasis and Crohn’s disease.
Conclusion
The relationship between psoriasis and Crohn’s disease highlights the importance of understanding immune mechanisms.
